Yahoo
KSE - Delayed Quote KRW

Samsung Biologics Co.,Ltd. (207940.KS)

1,516,000.00 -4,000.00 (-0.26%)
At close: November 6 at 3:30:27 PM GMT+9
View in AlphaSpace Currency in KRW All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
2,433,935,496.84
2,247,807,426.55
1,659,255,402.66
1,666,228,521.44
953,047,810.08
Investing Cash Flow
-2,385,290,643.97
-1,862,425,927.87
-1,243,776,304.34
-1,566,305,449.62
-3,106,477,133.45
Financing Cash Flow
-510,641,391.91
-620,504,462.84
-433,788,285.23
-635,049,948.36
3,000,080,259.53
End Cash Position
247,482,307.69
148,851,266.52
391,221,617.20
367,937,365.04
890,819,570.65
Capital Expenditure
-859,259,226.26
-1,475,073,515.28
-1,377,525,533.93
-1,105,324,663.01
-1,009,225,611
Issuance of Capital Stock
--
--
--
--
3,200,751,000
Issuance of Debt
84,453,486.10
85,000,000
1,129,659,176.80
803,500,000
805,653,000
Repayment of Debt
--
-250,000,000
-1,418,182,000
-1,280,840,298.12
-937,342,928.12
Repurchase of Capital Stock
--
-92,012,513.65
--
--
--
Free Cash Flow
1,574,676,270.58
772,733,911.27
281,729,868.73
560,903,858.43
-56,177,800.92
12/31/2022 - 11/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: